| Completed | 4 | 50 | Europe | Liraglutide, Trade name: Victoza, EV Product Code: SUB25238, Name of the Marketing Authorisation Holder: Novo Nordisk, Marketing Authorisation number: EU/1/09/529/001, ATC code: A10BX07, CAS number 204656-20-2, Liraglutide - Placebo, Placebo | Leiden University Medical Center, Novo Nordisk A/S | Diabetes Mellitus Type 2, Metabolic Syndrome, Cardiovascular Disease, Diastolic Dysfunction, Fatty Liver | 03/16 | 03/16 | | |
LIGHT-ON, NCT02147925: Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects |
|
|
| Completed | 4 | 75 | RoW | Liraglutide combined with metformin, Victoza®, Novo Nordisk, Insulin glargine combined with metformin, Lantus®, Sanofi, Sitagliptin combined with metformin, Januvia®, Merck & Co. Inc. | Sun Yat-sen University | Non-alcoholic Fatty Liver Disease | 04/17 | 04/17 | | |
